Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century
Redigert av Asa Oxner, S. Balaji, Paul Shapshak, Pandjassarame Kangueane, Lynette J. Menezes, John T. Sinnott, Charurut Somboonwit, 2024.
In the face of recent viral outbreaks and a global viral pandemic, the necessity for innovation and continued rapid advancement in viral diagnosis and treatment methods has become even more apparent. Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century explores the latest advances in virology and trends in clinical practice, focused on foundational principles and advancements expected to significantly impact this field. Chapters address SARS-CoV-2, Ebola, Zika, Mpox, and Hepatitis C, among other key viral threats, before presenting a detailed analysis of antiviral agents broadly and concerning specific vulnerable populations such as stem cell and solid organ transplant recipients. It is designed as a helpful resource for medical students, scientists, and professionals, bridging current practice and future applications and inspiring further innovations and improvements in global health.
Innbundet
Pocket — ikke tilgjengelig
E-bok — ikke tilgjengelig
Lydbok — ikke tilgjengelig
Språk: Engelsk
Normalpris: 3 349,-
3 014,-
Spar 335,-
Ikke tilgjengelig for Klikk&Hent
Midlertidig utsolgtBestillingsvare. Forventes sendt om ca 20 dager
Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century
Redigert av Asa Oxner, S. Balaji, Paul Shapshak, Pandjassarame Kangueane, Lynette J. Menezes, John T. Sinnott, Charurut Somboonwit, 2024.
In the face of recent viral outbreaks and a global viral pandemic, the necessity for innovation and continued rapid advancement in viral diagnosis and treatment methods has become even more apparent. Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century explores the latest advances in virology and trends in clinical practice, focused on foundational principles and advancements expected to significantly impact this field. Chapters address SARS-CoV-2, Ebola, Zika, Mpox, and Hepatitis C, among other key viral threats, before presenting a detailed analysis of antiviral agents broadly and concerning specific vulnerable populations such as stem cell and solid organ transplant recipients. It is designed as a helpful resource for medical students, scientists, and professionals, bridging current practice and future applications and inspiring further innovations and improvements in global health.